Analyst Ratings For OvaScience (NASDAQ:OVAS)
Today, HC Wainwright reiterated its Buy rating on OvaScience (NASDAQ:OVAS) with a price target of $15.00.
Some recent analyst ratings include
- 3/16/2018-HC Wainwright Reiterated Rating of Buy.
- 8/3/2017-Oppenheimer Reiterated Rating of Hold.
- 4/18/2017-Credit Suisse Group Reiterated Rating of Underperform .
- 8/10/2016-JMP Securities Reiterated Rating of Neutral.
- 5/8/2016-Leerink Swann Reiterated Rating of Hold.
Recent Insider Trading Activity For OvaScience (NASDAQ:OVAS)
OvaScience (NASDAQ:OVAS) has insider ownership of 9.50% and institutional ownership of 43.79%.
- On 6/1/2016 Michelle Dipp, CEO, bought 425,000 with an average share price of $7.00 per share and the total transaction amounting to $2,975,000.00.
- On 5/18/2016 Michelle Dipp, CEO, bought 20,000 with an average share price of $7.86 per share and the total transaction amounting to $157,200.00.
- On 5/17/2016 Michelle Dipp, CEO, bought 40,000 with an average share price of $7.63 per share and the total transaction amounting to $305,200.00.
- On 5/13/2016 Richard Aldrich, Director, bought 36,095 with an average share price of $6.94 per share and the total transaction amounting to $250,499.30.
- On 5/11/2016 Richard Aldrich, Director, bought 20,000 with an average share price of $7.64 per share and the total transaction amounting to $152,800.00.
- On 5/10/2016 Michelle Dipp, CEO, bought 19,900 with an average share price of $7.72 per share and the total transaction amounting to $153,628.00.
- On 5/10/2016 Paul W.D. Chapman, COO, bought 3,100 with an average share price of $7.37 per share and the total transaction amounting to $22,847.00.
Recent Trading Activity for OvaScience (NASDAQ:OVAS)
Shares of OvaScience closed the previous trading session at 0.94 down -0.04 4.02% with 0.9750999808311462 shares trading hands.